Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Blood Advances|July 10, 2024
The clinical picture of Castleman disease: a systematic review and meta-analysisChristian Hoffmann, Eric Oksenhendler, Sarah Littler, et al.
Rheumatology (Oxford, England)|August 11, 2020
HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related diseaseMitsuhiro Kawano, Satoshi Hara, Akihiro Yachie, et al.
Case Reports in Oncology|November 1, 2021
TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 TherapyCorinne Williams, Alexis Phillips, Vikram Aggarwal, et al.
Rheumatology (Oxford, England)|December 18, 2023
Lymphadenopathy in the rheumatology practice: a pragmatic approachStefano Rodolfi, Emanuel Della-Torre, Lucia Bongiovanni, et al.
JAMA Dermatology|February 22, 2013
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clueDavid C Fajgenbaum, David Fajgenbaum, Misha Rosenbach, et al.
Journal of Cellular and Molecular Medicine|April 30, 2022
Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFROAlexis D Phillips, Joseph J Kakkis, Patricia Y Tsao, et al.
The Lancet. Haematology|February 5, 2025
Pioneering a new field of computational pharmacophenomics to unlock the life-saving potential of existing medicinesDavid C Fajgenbaum, Sally Nijim, Grant Mitchell, et al.
Ejhaem|September 2, 2022
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysisYoshito Nishimura, Midori Filiz Nishimura, David C Fajgenbaum, et al.
JAMA Network Open|May 5, 2025
Rare Disease Drug RepurposingSally Nijim, Ania Korsunska, Joseph Zinski, et al.
Plos Medicine|April 10, 2026
Correction: Quantify unmet medical need across the disease landscape - A large language model-based methodologyElliott W Sharp, Nicholas Fragola, Charlotte Blewitt, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Blood Advances|July 10, 2024
The clinical picture of Castleman disease: a systematic review and meta-analysisChristian Hoffmann, Eric Oksenhendler, Sarah Littler, et al.
Rheumatology (Oxford, England)|August 11, 2020
HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related diseaseMitsuhiro Kawano, Satoshi Hara, Akihiro Yachie, et al.
Case Reports in Oncology|November 1, 2021
TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 TherapyCorinne Williams, Alexis Phillips, Vikram Aggarwal, et al.
Rheumatology (Oxford, England)|December 18, 2023
Lymphadenopathy in the rheumatology practice: a pragmatic approachStefano Rodolfi, Emanuel Della-Torre, Lucia Bongiovanni, et al.
JAMA Dermatology|February 22, 2013
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clueDavid C Fajgenbaum, David Fajgenbaum, Misha Rosenbach, et al.
Journal of Cellular and Molecular Medicine|April 30, 2022
Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFROAlexis D Phillips, Joseph J Kakkis, Patricia Y Tsao, et al.
The Lancet. Haematology|February 5, 2025
Pioneering a new field of computational pharmacophenomics to unlock the life-saving potential of existing medicinesDavid C Fajgenbaum, Sally Nijim, Grant Mitchell, et al.
Ejhaem|September 2, 2022
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysisYoshito Nishimura, Midori Filiz Nishimura, David C Fajgenbaum, et al.
JAMA Network Open|May 5, 2025
Rare Disease Drug RepurposingSally Nijim, Ania Korsunska, Joseph Zinski, et al.
Plos Medicine|April 10, 2026
Correction: Quantify unmet medical need across the disease landscape - A large language model-based methodologyElliott W Sharp, Nicholas Fragola, Charlotte Blewitt, et al.
Pageof 12